STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Sensient Technology Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing overview – Sensient Technologies Corp. (SXT)

Director Deborah McKeithan-Gebhardt reported a routine change to her equity position on 30 June 2025. The transaction involved the acquisition of 83.054 deferred stock units under the company’s Directors’ Deferred Compensation Plan. These units convert to common stock on a one-for-one basis and will be issued when the director’s board service ends.

Following the transaction, McKeithan-Gebhardt’s total beneficial ownership stands at 16,280.531 shares of common stock held directly and 5,468.395 deferred stock units, for an aggregated exposure of roughly 21,749 shares. No common shares were bought or sold in the open market, and no cash consideration was exchanged; the additional units reflect fee deferral rather than a discretionary share purchase.

The filing does not disclose any option grants, sales, or derivative disposals, and there are no indications of material changes to the insider’s overall ownership percentage or to the company’s capital structure. Given the small size of the award (≈0.002% of SXT’s ~45 million shares outstanding), the transaction is considered routine and non-material from a liquidity or control standpoint. However, the directionally positive addition may still be interpreted by some investors as a signal of ongoing board alignment with shareholder interests.

Positive
  • Director increased ownership by 83.054 deferred units, reinforcing alignment with shareholders.
Negative
  • None.

Insights

TL;DR: Minor fee-deferral share credit; immaterial to valuation, mildly positive for governance optics.

The 83-share deferred stock credit increases the director’s stake to roughly 21.7 k shares, still less than 0.05 % of shares outstanding. Because no cash changed hands and there was no open-market activity, the filing has negligible impact on supply-demand dynamics or intrinsic value. Nevertheless, continued accumulation—even via automatic fee deferrals—supports a narrative of board-level alignment. I classify the disclosure as not impactful for near-term price action, but modestly positive for corporate governance sentiment.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McKeithan Gebhardt Deborah

(Last) (First) (Middle)
777 EAST WISCONSIN AVENUE

(Street)
MILWAUKEE WI 53202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 16,280.531(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock (2) 06/30/2025 A(3) 83.054 (4) (4) Common Stock 83.054 $0 5,468.395 D
Explanation of Responses:
1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
2. Deferred stock converts to common stock on a one-for-one basis.
3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
/s/ John J. Manning, Attorney-in-Fact for Ms. McKeithan-Gebhardt 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Sensient Technologies (SXT) shares does Director Deborah McKeithan-Gebhardt now own?

16,280.531 common shares plus 5,468.395 deferred stock units, totalling about 21,749 equivalent shares.

What type of transaction was reported in the Form 4 for SXT?

An acquisition (A) of 83.054 deferred stock units through the Director fee deferral plan.

Did the director buy or sell SXT shares on the open market?

No. The filing reflects a non-cash fee deferral; there was no market purchase or sale.

When will the deferred stock units convert to SXT common stock?

They convert one-for-one upon termination of the director’s board service.

Is the reported transaction material to SXT shareholders?

Given it represents roughly 0.002 % of outstanding shares, the impact is considered immaterial.
Sensient Tech

NYSE:SXT

SXT Rankings

SXT Latest News

SXT Latest SEC Filings

SXT Stock Data

4.03B
41.81M
1.57%
102.59%
3.85%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
MILWAUKEE